RNA Formulation Videos
-
Enhancing Gene Editing Outcomes And Safety for Clinical Translation
5/6/2026
Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.
-
How To Bring (Any) mRNA To Life: Simplifying Nucleic Acid Encapsulation
5/6/2024
New technologies for the encapsulation of nucleic acids, such as FDmiX, can potentially overcome limitations of currently available standard mixing technologies.
-
LNP And Liposomal Center Of Excellence
3/10/2026
A connected development pathway supports smoother scale-up and greater consistency for LNP-based therapeutics. Explore how integrated expertise across key stages helps teams accelerate progress.
-
Strategies For Scaling Up mRNA Manufacturing
4/11/2022
The clinical promise of mRNA therapeutics and vaccines is clear, but compared to monoclonal antibodies or viral vectors, their novelty also brings new challenges to the manufacturing process.
-
Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics
12/12/2024
Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.
-
Lipids Center Of Excellence
4/14/2026
Examine high-quality, GMP-compliant lipids that are engineered for pharmaceutical and gene therapy applications, with options ranging from standard formulations to custom blends for improved stability.
-
Face- Phase-Off: Matching CDMO Capabilities To Your mRNA-LNP Development Stage
2/10/2025
There are many different criteria for selecting a CDMO for your mRNA products. Arcturus’ Qian Ruan explains that a product’s stage of development and the specific needs inherent to that phase of development should be an important guide for companies today, especially given the expansion of the outsourcing sector and the wide range of capabilities.
-
The mRNA Journey: From Design To LNP-Ready Molecules For Research
11/25/2025
Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.
-
The Latest And Greatest Technological Innovations In mRNA-LNP Production
2/10/2025
In this segment, Replicate Biosciences’ Andy Geall, Qian Ruan, & Alex Aust identify the most promising technological and raw material innovations that are influencing the drug substance and drug product production processes at CDMOs.
-
How To Successfully Control The Upscaling Of Your LNP Formulation
5/28/2025
Discover key strategies for controlling LNP formulation and upscaling. Explore the science behind lipid nanoparticles, critical parameters, and achieving effective turbulent mixing for optimal outcomes.